drugset / Trial / NCT05818735

Effect of Electroacupuncture on Treating the First-episode Depression

NCT05818735

RandomizedParallel-groupDouble-blindTreatment

Summary

Depression is a disease that endangers the physical and mental health of all human beings. Only 30-40% of patients with initial episode depression are cured after treatment with antidepressants. Acupuncture is a widely recognized therapy to treat depression in clinical practice, and it can effectively relieve the depressive mood and improve related physical symtoms in patients with mild to moderate depression. This randomised controlled trial (RCT) is aimed to investigate the efficacy and safety of electroacupuncture (EA) in the treatment for patients with the first-episode of mild to moderate depression.

Timeline

Start
2023-12-01
Primary completion
2025-12-31
Completion
2026-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 10 mg Oral
Comparator Escitalopram Small molecule 20 mg Oral

Indications